Cytel’s Solara Selected as 2021 Citeline Awards Finalist
WALTHAM, MASS - Cytel’s new trial strategy platform , Solara, has been shortlisted in the Best Sponsor-facing Technology Initiative category in the 2021 Citeline Awards.
Previously known as the CARE Awards, the Citeline Awards were created by PharmaIntelligence to recognize accomplishments of the highest achievers across the biopharmaceutical industry.
The Best Sponsor-facing Technology Initiative category recognizes the vital importance of using the most sophisticated platforms for use during clinical trials. The judges will be looking for the product or suite of products that help study teams better manage and oversee clinical trial activities.
Solara enables medical, operational, commercial, and statistical leaders to leverage massive computational power to simulate thousands of possible clinical trial designs in under an hour. This enables cross-functional teams to explore an exponentially larger design space to identify alternatives that optimize speed, savings, and probability of success.
The winning entry will be announced during an in-person networking event at the Hyatt Regency Boston, MA on Thursday October 14, 2021.
Cytel's Chief Scientific Officer, Dr. Yannis Jemiai, whose vision shaped the development of Solara, said he was delighted that it had been shortlisted as a finalist for the Citeline Awards.
"We have always believed that better trial design is critical in improving clinical development success rates. The impact on bringing lifesaving therapies to market quickly and efficiently could be immense. Using cloud technology and advanced clinical trial simulation algorithms, sponsors are now able to assemble evidence and facilitate cooperation amongst different players in the product life-cycle. By efficiently exploring the extensive design space, Solara strives to empower life sciences leaders to make strategic and ethical decisions that are grounded in the most expansive data. We are pleased that the full potential of this product to transform the path of new medicines, is being recognized by the industry."
About Cytel: Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value and make confident, evidence-based decisions. Our experts deliver industry-leading software, data-driven analytics, real-world evidence and strategic consulting. Headquartered in Waltham, Massachusetts, Cytel has more than 1,400 employees across North America, Europe and Asia. For more information about Cytel, please visit us at www.cytel.com. You also can follow us on LinkedIn and Twitter and like us on Facebook.